Therefore, in the present study, we compared the use of an Ang II Type 1 receptor blocker (Losartan), SGLT2 inhibition (Empagliflozin) or the combination of both treatments on the Ang II-dependent effects on kidney damage in rats. The gene discussed is AGT; the disease is Nephropathy.